Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
IP Indian Journal of Immunology and Respiratory Medicine is Scopus-indexed (Q4, CiteScore 0.2). Published by IP Innovative Publication Pvt. Ltd..
Checked against the index lists dated .
ISSN 2581-4214Verify ISSN ↗2581-4222Verify ISSN ↗
Publisher: IP Innovative Publication Pvt. Ltd.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pulmonary and Respiratory Medicine | 158 / 165 | 4th | Q4 |
| Immunology and Allergy | 230 / 234 | 1st | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2021–present, best quartile Q4, CiteScore 0.2.
IP Indian Journal of Immunology and Respiratory Medicine is Q4 in Pulmonary and Respiratory Medicine (rank 158 of 165) and Q4 in Immunology and Allergy (rank 230 of 234), by CiteScore 2025.
IP Indian Journal of Immunology and Respiratory Medicine is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.2, quartile Q4, 4th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.123, quartile Q4, with an H-index of 3.
IP Indian Journal of Immunology and Respiratory Medicine is published by IP Innovative Publication Pvt. Ltd. Its print ISSN is 2581-4214 and its online ISSN is 2581-4222.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
IP Indian Journal of Immunology and Respiratory Medicine has an h-index of 7 and a 2-year mean of 0.17 citations per paper (OpenAlex). Its Scopus CiteScore is 0.2, quartile Q4. On 2-year citations it ranks #144 of 160 Scopus journals in Pulmonary and Respiratory Medicine.
IP Indian Journal of Immunology and Respiratory Medicine published 45 papers in 2025; its busiest recent year was 2021 with 100. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 78 research articles (2024–2026), authors are most often from India (93.4%), Saudi Arabia (2.6%) and Sri Lanka (1.3%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.